Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

214.78
Delayed Data
As of 4:00pm ET
 -1.36 / -0.63%
Today’s Change
184.50
Today|||52-Week Range
301.98
+2.27%
Year-to-Date
Today's Trade
12:45pm / TheStreet.com - Paid Partner Content
Back Into Allergan
Jan 12 / TheStreet.com - Paid Partner Content
Intermede Investment Partners Ltd Buys Wells Fargo & Co, Facebook Inc, Amgen Inc, Sel...
11:41am / GuruFocus News - Paid Partner Content
Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
Jan 12 / Zacks.com - Paid Partner Content
Biotech Sector to See M&A, Earnings Action
11:13am / TheStreet.com - Paid Partner Content
Cramer: Trump Doesn't Seem to Care About the Trump Rally
Jan 11 / TheStreet.com - Paid Partner Content
Jobless Claims and Trimming GLD: Best of Kass
Jan 13 / TheStreet.com - Paid Partner Content
Trump: Drug companies 'getting away with murder'
Jan 11 / CNNMoney.com
Today's Trades
Jan 13 / TheStreet.com - Paid Partner Content
Getting Shorter
Jan 11 / TheStreet.com - Paid Partner Content
Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit
Jan 13 / Zacks.com - Paid Partner Content
Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes
Jan 10 / MotleyFool.com - Paid Partner Content
Reliance Trust Co of Delaware Buys Bank of America Corporation, Allergan PLC, SPDR S&...
Jan 13 / GuruFocus News - Paid Partner Content
Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit
Jan 09 / Zacks.com - Paid Partner Content
Jerome Dodson Buys Allergan PLC, McKesson Corp, Progressive Corp, Sells Ciena Corp, C...
Jan 12 / GuruFocus News - Paid Partner Content
Teva Falls on Disappointing 2017 Sales & Earnings Guidance
Jan 09 / Zacks.com - Paid Partner Content
My Takeaways and Observations
Jan 12 / TheStreet.com - Paid Partner Content
Allergan CEO on the Hot Seat: Here's What He Had to Say
Jan 06 / MotleyFool.com - Paid Partner Content
Biotechs stage recovery from Trump line of fire
Jan 12 / FT.com - Paid Partner Content
Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 V...
Jan 06 / Zacks.com - Paid Partner Content
Trump's Remarks Show Why Pharma Sector Is 'Barely Investable': More Squawk From Jim C...
Jan 12 / TheStreet.com - Paid Partner Content
Allergan (AGN) Liletta sNDA Accepted for Review in the U.S.
Jan 05 / Zacks.com - Paid Partner Content
Biotech Just Got Trumped
Jan 12 / TheStreet.com - Paid Partner Content
Allergan Natrelle Inspira Breast Implants Approved in the U.S.
Jan 04 / Zacks.com - Paid Partner Content
Gobbling Up Some Allergan
Jan 12 / TheStreet.com - Paid Partner Content